Immortal person time bias in pharmacoepidemiological studies of antihypertensive drugs.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Cardiology

• Publication date

  2011-09-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.amjcard.2011.06.031PMID 21884882
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals

  2011cited by this paper
• Use of Angiotensin Receptor Blockers and the Risk of Cancer

  2011cited by this paper
• Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.

  2011cited by this paper
• Angiotensin II receptor blockers and risk of cancer in patients with systemic hypertension.

  2011cited by this paper
• Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials.

  2010cited by this paper
• Immortal time bias in pharmaco-epidemiology.

  2008cited by this paper
• Immortal time bias in observational studies of drug effects

  2007cited by this paper
• Long-term safety of antihypertensive therapy.

  2006cited by this paper

• Associations between statin use and risk of non‐Hodgkin lymphomas by subtype

  2018cites this paper
• Associations between statin use and non‐Hodgkin lymphoma (NHL) risk and survival: a meta‐analysis

  2017cites this paper
• Spironolactone and the risk of urinary tract cancer in patients with hypertension: a nationwide population-based retrospective case–control study

  2017cites this paper
• The Use of Telmisartan and the Incidence of Cancer.

  2016cites this paper
• Regular inhaled corticosteroids in adult-onset asthma and the risk for future cancer: a population-based cohort study with proper person-time analysis

  2015cites this paper
• The risk of malignant neoplasms development at the intake of different classes of antihypertensive drugs

  2013cites this paper
• Long-term use of angiotensin II receptor blockers and risk of cancer: a population-based cohort analysis.

  2013cites this paper
• Long-Term Use of Angiotensin Receptor Blockers and the Risk of Cancer

  2012cites this paper